![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, April 01, 2017 11:02:41 AM
Nothing has changed fundementaly and in fact with every day that passes we become fundementaly stronger then the previous week.
REVENUE IS CLOSER THEN EVER TO STARTING!
MORE ANNOUNCEMENTS ON NEW PRE CLINICAL TRIALS FOR THERE CREAM WILL BE ANNOUNCED IN AS EARLY AS 45 days!
SUBLINGUAL TABLET REVENUE TO START LATER THIS YEAR!
AND THE ONE I LIKE IS OUR MULTIPLE MYELOMA STUDY THAT IS SET UP FOR ORPHAN DRUG!
Patients will pay here and is why I remain long on this stock.
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM